Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 8 de 8
1.
Eur J Neurol ; 23(1): 190-5, 2016 Jan.
Article En | MEDLINE | ID: mdl-26498428

BACKGROUND AND PURPOSE: For many years deep brain stimulation (DBS) devices relied only on voltage-controlled stimulation (CV), but recently current-controlled devices have been developed and approved for new implants as well as for replacement of CV devices after battery drain. Constant-current (CC) stimulation has been demonstrated to be effective in new implanted parkinsonian and dystonic patients, but the effect of switching to CC therapy in patients chronically stimulated with CV implantable pulse generators (IPGs) has not been assessed. This report shows the results of a consecutive retrospective data collection performed at five Italian centers before and after replacement of constant-voltage with constant-current DBS devices, in order to verify the clinical efficacy and safety of this procedure. METHODS: Nineteen patients with Parkinson's disease or dystonic syndrome underwent DBS IPG CV/CC replacement. Clinical features and therapy satisfaction were assessed before surgery, 1 week after and 3 and 6 months after replacement. Programming settings and impedances were recorded before removing the CV device and when the CC IPGs were switched on. RESULTS: The clinical outcome of CC stimulation was similar to that obtained with CV devices and remained stable at 3 and 6 months of follow-up. Impedance values recorded for CV and CC IPGs were similar. Ninety-five percent of patients and physicians were satisfied with mixed implants. No adverse events occurred after IPG replacement. CONCLUSION: Replacing CV with CC IPGs is a safe and effective procedure. Longer follow-up is necessary to better clarify the impact of CC stimulation on clinical outcome after chronic stimulation in CV mode.


Deep Brain Stimulation/methods , Dystonic Disorders/therapy , Electricity , Parkinson Disease/therapy , Electrodes, Implanted , Follow-Up Studies , Humans , Retrospective Studies , Treatment Outcome
2.
J Neurosurg Sci ; 57(1): 63-7, 2013 Mar.
Article En | MEDLINE | ID: mdl-23584221

AIM: Intracranial hemorrhage is an infrequent but potentially devastating complication associated with the placement of electrodes for deep brain stimulation (DBS). The objective of this retrospective review is to compare the risk of hemorrhage before and after the introduction of image-guided neuronavigation for the implant of electrodes for DBS. METHODS: We reviewed all DBS implant performed at our Institute between 1998 and 2010. In 63 of the 106 patients, the targeting was based on ventriculography and merge of CT/MRI. After 2006, in the latter 43 procedures, we introduced targeting based on the merging of angio CT and MRI.. In both implant techniques, microelectrode recording (MER) was used to better define the target. All DBS procedures were performed by a single surgeon (M.P.). Patients had postoperative imaging (MRI or CT) 4-24 h following surgery. RESULTS: In the group of patients implanted with the first targeting technique, 3 hematomas occurred and all of them solved with sequelae (one residual weakness and two hemiplegias.) After the introduction of neuronavigator, 2 hemorrhages occurred, one solved without sequelae while the second resulted in epileptic seizures. CONCLUSION: Although the incidence of hemorrhage occurred before and after the use of neuronavigation is the same, the severity is lower in the neuronavigated procedures. Targeting based on the merging of CT angiography and MRI T1/T2 seemed to increase the safety of the lead placement reducing the risk of sequelae related to bleeding. The use of MER was not found to be correlated with an increased hemorrhage rate.


Deep Brain Stimulation/adverse effects , Electrodes, Implanted/adverse effects , Intracranial Hemorrhages/etiology , Microelectrodes/adverse effects , Stereotaxic Techniques/standards , Deep Brain Stimulation/standards , Female , Humans , Incidence , Male , Middle Aged , Planning Techniques , Retrospective Studies , Treatment Outcome
3.
G Ital Med Lav Ergon ; 34(3 Suppl): 599-601, 2012.
Article It | MEDLINE | ID: mdl-23405727

INTRODUCTION: We evaluated the congenital malformation rate in the progeny of the personnel of the Salto di Quirra military base in Sardinia. METHODS: During 2011, we gathered questionnaire information on the reproductive history of 389 employees, more then 99% of those eligible for routine health surveillance. RESULTS: the observed congenital malformation rate (20.1 x 10(-3), 95% CI 6.3 - 33.8) was lower than that reported by the Italian Registries of Congenital Malformations, and it did not vary by exposure to radiofrequency, elf electromagnetic fields, and solvents, and by jobs associated with alleged exposure to nanoparticles or alpha radiation. CONCLUSIONS: Our findings suggest that the documented or alleged occupational exposures among the PISQ workforce did not increase the congenital malformation rate in the progeny.


Congenital Abnormalities/epidemiology , Congenital Abnormalities/genetics , Military Personnel , Adult , Humans , Italy , Military Facilities , Risk Assessment
4.
G Ital Med Lav Ergon ; 33(3 Suppl): 271-3, 2011.
Article It | MEDLINE | ID: mdl-23393854

A health surveillance program was implemented in 71 health care workers (HCW) exposed to a patient with active TB infection. A two-step tuberculin skin test (TST) was performed in all the exposed, and a QuantiFERON-TB Gold (QTF) test was scheduled for positive TST subjects. Clinical-radiological surveillance (CRS) was scheduled for subjects positive to TST and QTF or symptomatic. Thirty eight percent HCW were TST positive; 19% of them were also QTF positive and were referred to CRS. No clinical TB was observed among the exposed HCW. Comprehensive health surveillance allows to increase risk perception, compliance to HS and to reduce cost in respect to less cost-effective practices.


Health Personnel , Occupational Diseases/prevention & control , Occupational Exposure/prevention & control , Occupational Health , Population Surveillance , Tuberculosis/prevention & control , Adult , Female , Humans , Male , Middle Aged , Occupational Diseases/epidemiology , Tuberculosis/epidemiology , Young Adult
5.
Clin Lab ; 57(11-12): 859-66, 2011.
Article En | MEDLINE | ID: mdl-22239015

BACKGROUND: Oxidative stress may be directly or indirectly involved in the pathogenesis of Parkinson's disease (PD). 8-hydroxy-2'deoxyguanosine (8-OHdG) is the major product of DNA oxidative damage but its determination in plasma or urine may have controversial significance. The concentration of 8-OHdG not only depends on its oxidation rate but also on the efficacy of the DNA repairing systems. METHODS: We studied the ratio between 8-OHdG and 2-dG (the corresponding not hydroxylated base 2'-deoxyguanosine) in plasma and urine as a marker of oxydative stress in PD. This enabled the determination of the real DNA damage in terms of oxidation rate regardless of the efficacy of the DNA repairing mechanisms. RESULTS: We optimized two different analytical methods: one for 8-OHdG and the other for 2-dG, both based on a common preliminary solid-phase extraction step (SPE) followed by two different HPLC analytical separations with electrochemical detection (HPLC-ED). The reliability of these methods was confirmed by analysing plasma and urine samples collected in parkinsonian patients and in age-matched healthy control subjects. CONCLUSIONS: In urine samples, the measurement of 8-OHdG alone as well as the ratio 8-OHdG/2-dG were significantly different in healthy controls and PD patients. In plasma samples, only the ratio 8-OHdG/2-dG was significantly higher in PD compared to healthy controls showing that the ratio 8-OHdG/2-dG is a reliable diagnostic tool in studies on DNA oxydative damage.


Chromatography, High Pressure Liquid/methods , Deoxyglucose/analysis , Deoxyguanosine/analogs & derivatives , Parkinson Disease/metabolism , 8-Hydroxy-2'-Deoxyguanosine , Aged , Aged, 80 and over , Antiparkinson Agents/therapeutic use , Biomarkers , Case-Control Studies , DNA Damage , DNA Repair , Deoxyglucose/blood , Deoxyglucose/urine , Deoxyguanosine/analysis , Deoxyguanosine/blood , Deoxyguanosine/urine , Electrochemical Techniques , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Oxidative Stress , Parkinson Disease/blood , Parkinson Disease/drug therapy , Parkinson Disease/urine
7.
Arch Neurol ; 58(8): 1223-7, 2001 Aug.
Article En | MEDLINE | ID: mdl-11493162

BACKGROUND: Chronic bilateral subthalamic deep brain stimulation (STN-DBS) is known to improve motor function in patients with Parkinson disease (PD). However, the possible effects of STN-DBS on neuropsychological functions have been studied less. OBJECTIVE: To investigate the effects of STN-DBS on neuropsychological functions in PD. DESIGN: Before-after trial. PATIENTS AND METHODS: Fifteen consecutive patients were assessed before and 3 months after implantation of stimulators for STN-DBS (postsurgical assessment with the stimulators switched on). Both assessments were performed with patients in a drug-free condition. The neuropsychological battery consisted of tests measuring memory and visuospatial and frontal functions. RESULTS: The comparison between presurgical and postsurgical performance showed a moderate deterioration in verbal memory and prefrontal and visuospatial functions, and a moderate improvement in a prefrontal task and obsessive-compulsive traits. The motor state improved in all patients. CONCLUSION: Therapy with STN-DBS improves motor symptoms in PD without any clinically relevant neuropsychological deterioration.


Electric Stimulation Therapy/adverse effects , Memory , Parkinson Disease/surgery , Psychomotor Performance , Subthalamic Nucleus/surgery , Aged , Analysis of Variance , Electric Stimulation Therapy/methods , Female , Humans , Learning , Male , Middle Aged , Neuropsychological Tests , Parkinson Disease/physiopathology , Parkinson Disease/psychology
...